Lobular carcinoma in situ

HY Wen, E Brogi - Surgical pathology clinics, 2018 - Elsevier
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …
被引用次数：150 相关文章

Lobular Carcinoma In Situ

HY Wen, E Brogi - Surgical pathology clinics, 2018 - pubmed.ncbi.nlm.nih.gov
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Lobular Carcinoma In Situ

HY Wen, E Brogi - Surgical Pathology Clinics, 2018 - surgpath.theclinics.com
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Lobular Carcinoma In Situ.

HY Wen, E Brogi - Surgical Pathology Clinics, 2017 - europepmc.org
LCIS is both a risk factor and a non-obligate precursor of breast carcinoma. The relative risk
of invasive carcinoma after a diagnosis of classic LCIS is approximately 9-10 times that of …

[引用][C] Lobular Carcinoma In Situ

HY Wen, E Brogi - Surgical Pathology Clinics, 2018 - cir.nii.ac.jp
[HTML] nih.gov

[HTML][HTML] Lobular Carcinoma in Situ

HY Wen, E Brogi - Surgical pathology clinics, 2018 - ncbi.nlm.nih.gov
LCIS is both a risk factor and a non-obligate precursor of breast carcinoma. The relative risk
of invasive carcinoma after a diagnosis of classic LCIS is approximately 9-10 times that of …

Lobular Carcinoma In Situ.

HY Wen, E Brogi - Surgical Pathology Clinics, 2017 - europepmc.org
LCIS is both a risk factor and a non-obligate precursor of breast carcinoma. The relative risk
of invasive carcinoma after a diagnosis of classic LCIS is approximately 9-10 times that of …